Fleet Glycerin Suppositories Recalled for Storage Temperature Violations
Fleet Glycerin Suppositories distributed nationwide from April 30 to June 10, 2022, are being recalled because the product was held outside appropriate storage temperature conditions.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving a manufacturing practice deviation for improper storage temperature. No illnesses or injuries have been reported. The hazard is a potential product quality issue rather than a direct safety threat, consistent with a precautionary recall.
Plain-English summary
Fleet Glycerin Suppositories 50 CT (SKU 917001) distributed through Family Dollar stores nationwide between April 30 and June 10, 2022, are subject to this recall.
The recall is due to Current Good Manufacturing Practice (CGMP) deviations. The affected product was held outside appropriate storage temperature conditions, which may compromise product quality and reliability.
Consumers who obtained this product during the affected timeframe should no longer use it.
The recalled product
- Product
- FLEET GLYCERIN SUPPOSITORIES 50 CT distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Hazard
- storage-temperature
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- SKU: 917001
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27